HOME >> BIOLOGY >> NEWS
Common Anti-Viral Medication Prevents Severe Eye Herpes

A new study led by University of California San Francisco researchers has found that acyclovir, a common anti-viral drug used to treat and prevent genital herpes, can also prevent the recurrence of herpes disease of the eye. The study marks the first time a treatment has been proven effective in preventing recurrence of the eye disease.

The study, published in the July 30 edition of the New England Journal of Medicine, shows that acyclovir is particularly effective in preventing recurrences of a serious strain of the eye disease, called stromal keratitis, which can lead to scarring of the cornea with vision loss and blindness.

The study found that the rate of recurrence of this blinding form of the disease dropped 50 percent when patients took 400 milligrams of acyclovir by mouth twice a day, said Chandler R. Dawson, MD, UCSF professor emeritus of ophthalmology and former director of UCSF's Francis I. Proctor Foundation for Research in Ophthalmology, who led the study.

The findings, Dawson said, are the key to preventing recurrences of a particularly harmful form of the disease that affects thousands of Americans each year. About 400,000 Americans have had some form of ocular herpes and some have recurrent eye infections. About 25 percent of the 50,000 Americans who experience some form of eye herpes each year have stromal keratitis.

The study's key finding, Dawson said, is that it identifies those patients with potentially blinding herpetic stromal keratitis who will benefit most from long-term acyclovir treatment. Most opthalmologists can diagnose this blinding disease by a simple clinical examination and treat these high risk patients with long-term preventive dose of acyclovir, Dawson said.

The results of the study are particularly promising because this dose of acyclovir has very few side effects, meaning patients can safely use the drug for prevention, Dawson said.

"This is the first time the drug has been used for prevention of the
'"/>

Contact: Diana Marszalek
dmarsza@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
29-Jul-1998


Page: 1 2

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... , ... In the wake of the success of IBBL’s ... biobanks was launched in July 2018, in an agreement between IBBL, the International ... Biotech Association (BBCMBA). The one-year pilot programme offered two testing schemes: ‘DNA quantification ...
(Date:3/27/2019)... ... March 27, 2019 , ... NDA Partners Chief Executive Officer ... Health & Pharma Biotechnology Award as the Best Life Sciences Management & Contract ... individuals and companies whose accomplishments have proved evidence of extensive expertise and skills, ...
(Date:3/25/2019)... , ... March 25, 2019 , ... ... Visikol, a contract research organisation focused on advancing drug discovery, have announced a ... imaging. , Tissue clearing methods, which are essential to get a better view ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... 16, 2019 , ... On April 24th, the Federal Laboratory ... Center for Environmental Health Research (USACEHR), with an award for their cooperative effort ... veteran-owned company located at the Frederick Innovative Technology Center, Inc. (FITCI) on Metropolitan ...
(Date:4/10/2019)... ... April 10, 2019 , ... After more than three months of renovation, Lajollacooks4u ... equipped with updated appliances and modern lighting and fixtures, and will provide additional workspace ... “We’ve seen tremendous growth in the demand for our team-building events and cooking classes ...
(Date:4/8/2019)... (PRWEB) , ... April 08, 2019 , ... US ... investors a $15 million preferred equity investment in the privately held pharmaceutical company, S1 ... leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the field of Regenerative ... across the United States and Canada since 2004. The primary indications for VetStem ... in the dog, cat, and horse. Recently, VetStem teamed up with the ...
Breaking Biology Technology:
Cached News: